Post-approval studies (Phase 4)Study completedNCT00436163
What this trial is testing
Peginterferon Alfa-2a (40KD) (PEGASYS®) in Participants With Hepatitis B Envelope Antigen (HBeAg) - Positive Chronic Hepatitis B
Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 39